Kidney Diseases

Urinary Glucose Concentration as a Predictor of Proteinuria Reduction in Chronic Kidney Disease Patients Treated with Sodium-Glucose Cotransporter 2 Inhibitors

By Xueqi Wang, Jie Wang, Shuwen Zhou, Guangyan Cai

Trial in peopleInterventions

The paper

Xueqi Wang, Jie Wang, Shuwen Zhou, Guangyan Cai

Nankai University; Chinese PLA General Hospital

Kidney Diseases, 14 Jul 2026

doi.org/10.1159/000553450 PubMed 42610122

The American Journal of Cardiology8 Oct 2026
Drug class linked to fewer deaths or complications in kidney disease
Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Clinical Pharmacology and Therapeutics4 Oct 2026
SGLT2 inhibitors raise genital but not urinary infection risk